Abiopharma

🔍 Nijhawan Pardeep (Director)

Company: Edesa Biotech, Inc. (EDSA)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 10,444 shares of Common Shares (Direct)
  Date: 2026-01-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 501,822.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: Held by Pardeep Nijhawan Medicine Professional Corporation | shares_owned_after: 341,702.00 | Footnotes: F2
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: Held by The New Nijhawan Family Trust 2015 | shares_owned_after: 32,609.00 | Footnotes: F3
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: Held by The Digestive Health Clinic Inc. | shares_owned_after: 32,013.00 | Footnotes: F2
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: Held by 1968160 Ontario Inc. | shares_owned_after: 53,104.00 | Footnotes: F2

Footnotes:

• F1: Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
• F2: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
• F3: Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.